Your browser doesn't support javascript.
loading
Clinical and radiological features of posterior cortical atrophy (PCA) in a GRN mutation carrier: a case report.
Giunta, M; Libri, I; Premi, E; Brattini, C; Paghera, B; Archetti, S; Gasparotti, R; Padovani, A; Borroni, B; Benussi, A.
Afiliação
  • Giunta M; Centre for Neurodegenerative Disorders, Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy.
  • Libri I; Centre for Neurodegenerative Disorders, Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy.
  • Premi E; Stroke Unit, ASST Spedali Civili, Brescia, Italy.
  • Brattini C; Centre for Neurodegenerative Disorders, Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy.
  • Paghera B; Nuclear Medicine Department, University of Brescia, Brescia, Italy.
  • Archetti S; Biotechnology Laboratory, Department of Diagnostics, Spedali Civili Hospital, Brescia, Italy.
  • Gasparotti R; Neuroradiology Unit, University of Brescia, Brescia, Italy.
  • Padovani A; Centre for Neurodegenerative Disorders, Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy.
  • Borroni B; Centre for Neurodegenerative Disorders, Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy.
  • Benussi A; Centre for Neurodegenerative Disorders, Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy.
Eur J Neurol ; 28(1): 344-348, 2021 01.
Article em En | MEDLINE | ID: mdl-33030763
ABSTRACT
BACKGROUND AND

PURPOSE:

Posterior cortical atrophy (PCA) is a rare neurodegenerative syndrome, defined by a distinctive clinical-radiological profile, with Alzheimer's disease (AD) pathology accounting for the majority of cases. The aim of this report was to present the case of a patient with impairment of visual and constructional abilities as initial manifestations.

METHOD:

The patient underwent a multidimensional assessment, including neuropsychological evaluation, structural and functional imaging and genetic screening.

RESULTS:

Neurological and neuropsychological assessment showed an impairment of constructive and visuo-spatial skills, associated with dyscalculia, simultanagnosia, optic ataxia and oculomotor apraxia. In accordance with the latest consensus criteria, a diagnosis of PCA was made. Consistent with the clinical findings, structural and functional imaging showed a peculiar pattern of atrophy with primary involvement of right parieto-occipital cortices, whereas cerebrospinal fluid biochemical analysis did not reveal a profile compatible with AD pathology. Genetic screening identified a known pathogenic GRN mutation.

CONCLUSION:

We present a case of PCA in a GRN mutation carrier in whom a concomitant AD pathological process was excluded. Consequently, although lacking histological data, our case suggests GRN-related pathology causative of PCA. Through this report we provide further evidence for a new neurodegenerative pathway leading to PCA, extending the clinical spectrum of GRN-associated phenotypes.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doença de Alzheimer Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doença de Alzheimer Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article